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Abstract. Online e-health systems are being proposed and developed at
an ever increasing rate. However, the progress relies on the interoperabil-
ity of local healthcare software, and is often hampered by ad hoc methods
leading to closed systems with a multitude of protocols, terminologies,
and design approaches. AOSE seems intuitively a good approach to de-
veloping more open systems. While agent-based e-health systems have
been developed, the general hypothesis of the suitability of AOSE has
not been evaluated. In this paper, we test that hypothesis, including a
case study of applying a regulated agent methodology to a particular
real-world e-health system, and present an analysis of the strengths and
weaknesses of AOSE for e-health.
Keywords: Health systems, Normative environments, Organizational
Agent Architectures, Contracts, System of Systems
1 Introduction
Large-scale and flexible systems are increasingly needed to fulfil the emerging
requirements of complex domains. One typical example is healthcare, which is
rapidly becoming more and more dependent on large-scale integrated software
systems. On the one hand, these systems offer new and innovative ways to im-
prove patient care; however, on the other, they also introduce complications and
risks that were never envisaged in the early days of healthcare computerisation.
Clearly, these complications affect the development of related software. A par-
ticular challenge is that the healthcare domain is separated into many disparate
organisations that often fall under different spheres of control. As a result, it is
common for systems to be constructed out of many divergent sub-systems; this
is termed a systems of systems (SoS). In this context, interactions can often take
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place between components that are managed by parties with conflicting goals,
different policies, incompatible data representations, and so on. Not surprisingly,
this can lead to serious challenges when integrating these different systems in
a trustworthy, consistent manner, leading to the emergence of strict regulatory
controls to manage not only the internal behaviour of organisations, but also the
interactions that may take place between multiple organisations.
While multi-agent technology has emerged over the last decade as a new
software engineering paradigm for building complex, adaptive systems in dis-
tributed, heterogeneous environments, it is still not mainstream in its domain
application. Nevertheless, it can be observed that many properties of the health-
care domain fit well with several concepts that arise in the area of multi-agent
systems, such as organisational autonomy, inherent regulatory frameworks, and
so on. It thus seems appropriate that introducing such principles to the develop-
ment of healthcare systems could offer many benefits. Indeed, there have been
several agent-based e-health systems developed over a period of many years, but
these they rarely employ explicit agent-oriented software engineering (AOSE)
methodologies and, as such, do not directly evaluate the suitability of AOSE to
this domain in particular.
Addressing this omission, in this paper we investigate the suitability of using
AOSE, and the common underlying concepts used in AOSE design and devel-
opment, for the creation of e-health systems. We wish to answer the following
question: To what extent is AOSE an approach that is appropriate to the devel-
opment of e-health systems? To represent AOSE in testing this hypothesis, we
take a specific methodology, ROMAS (Regulated Open Multi-agent Systems),
whose main concepts are introduced in Section 2. ROMAS is an AOSE method-
ology that guides developers all the way from the requirements analysis phase to
the actual implementation, taking into account the notions of agents, organiza-
tions, services and contracts. As ROMAS shares many of the same fundamental
concepts with other existing AOSE methodologies, it can be seen as an adequate
representative for testing the hypothesis. In this paper we apply the ROMAS
methodology to a particular (real) e-health system: ePCRN-IDEA [13, 12], with
the resulting system design being presented in Section 3. This system allows us
to exemplify the features of healthcare systems, so as to evaluate the suitability
of AOSE in addressing them. Ultimately, in Section 4, we identify a number
of strengths and weaknesses of AOSE for such systems, as well as suggesting
improvements to better support the needs of the domain. Finally, we conclude
the paper in Section 5.
2 Regulated Open Multi-agent Systems
In this section we introduce how ROMAS integrates the common AOSE concepts
of agents, roles, organizations, norms and contracts. A complete description of
ROMAS can be found in [9], so we address only the key aspects here. In RO-
MAS, agents, roles and organizations are defined through a formal social struc-















































Fig. 1. Overview of ROMAS architecture
summarized in Figure 1. Here, organizations represent a set of individuals and
institutions that need to coordinate resources and services across institutional
boundaries. In this context, agents represent individual parties who take on roles
in the system, within a given organization (e.g. a company), they can both of-
fer and consume services as part of the roles they play. Beyond this, virtual
organizations can also be built to coordinate resources and services across insti-
tutional boundaries. Importantly, each of these concepts must be strictly defined,
alongside their interrelations. Organizations are conceived as an effective mech-
anism for imposing not only structural restrictions on their relationships, but
also normative restrictions on their behaviour. These restrictions are formalized
in ROMAS by means of norms and contracts.
Norms in ROMAS are specified using the model described in [3], which de-
fines norms that control agent behaviour, the formation of groups of agents, the
global goals pursued by these groups and the relationships between entities and
their environment. Specifically, it allows norms to be defined: (i) at different
social levels (e.g. interaction and institutional levels); (ii) with different norm
types (e.g. constitutive, regulative and procedural); (iii) in a structured manner;
and (iv) dynamically, including later derogation. Figure 1 shows two types of
norms: (i) those that are are associated with each organization; and (ii) those
that are associated with each role. Clearly, the former must be complied with by
any organization member, while the latter must be complied with by all agents
playing that role.
Finally, ROMAS also allows interactions to be fomalized by means of con-
tracts. These are necessary when working in an open regulated system, to be able
to specify the expected behaviour of others without compromising their specific
implementation. ROMAS involves two types of contracts: social contracts and
contractual agreements. Social contracts can be defined as a statement of intent
that regulates behaviour among organizations and individuals. As shown in Fig-
ure 1, social contracts are used to formalize relationships: (i) between an agent
playing a role and its host organization (as indicated by the contract labelled
c1); and (ii) between two agents providing and consuming services (as indicated
by c2). Social order, thus, emerges from the negotiation of contracts about the
rights and duties of participants, rather than being given in advance. In contrast,
contractual agreements represent the commitments between several entities in
order to formalize an interchange of services or products (c3).
3 Application Case-Study: ePCRN-IDEA System
In this section we present a system architecture for recruiting patients for clinical
trials in real-time. First, Sections 3.1 and 3.2 introduces the domain context and
its challenges. Second, Section 3.3 describes the system design using ROMAS.
Finally, Section 3.4 analyzes how ROMAS deals with the main challenges of the
system.
3.1 ePCRN-IDEA Overview
Clinical trials are experiments by which the efficacy of medical treatments are
explored. They involve recruiting patients with specific characteristics to undergo
new treatments, so that the effectiveness and safety of those treatments can
be tested. However, a key challenge in this is recruiting sufficient patients to
ensure the results are meaningful. This has long been a difficult problem as
the requirements for participation are often very strict, making it difficult to
locate eligible patients. ePCRN-IDEA [12] is a new system under deployment in
the UK healthcare system that notifies practitioners in real-time whenever an
eligible patient is in consultation. When a patient visits a clinic, ePCRN-IDEA
compares their details against a database of trials; if the patient is eligible for one
or more, the practitioner is prompted to try to immediately recruit the patient
if they are interested.
3.2 Challenges in ePCRN-IDEA’s Development
Development of the ePCRN-IDEA system [13] has identified a number of core
challenges, which are typical of similar systems in the health domain. In this
light, this section briefly covers the most important of these identified challenges
to gain a better understanding of how AOSE might be able to benefit the devel-
opment process of such systems.
Integration of Independent Systems. In order to recruit eligible patients,
it is necessary for researchers, practitioners, patients, databases and clinics to
interact. This means that several independent institutions, which are completely
autonomous and have their own independent goals, must cooperate to achieve
a common objective. However, the integration of multiple heterogeneous and
autonomous systems can be a complicated and resource-consuming task. Some
of the issues that must be solved are: (i) Distributed Data – the required data
is spread widely across all organizations, frequently using different schemas; (ii)
Technical Interoperability – different organizations often use different (poten-
tially incompatible) technologies; (iii) Process Interoperability – different orga-

















































Fig. 2. ePCRN-IDEA organizational structure.
their goals; (iv) Semantic Interoperability – different organizations often utilise
different vocabularies and coding schemes, making it difficult to understand the
data of others; (v) Trustworthiness – little trust exists between different organi-
zations, particularly those with conflicting goals and interests. In consequence,
healthcare systems that consist of multiple organizations must take all these
aspects into account to ensure successful operation.
Regulation of Independent Systems. Healthcare systems must fulfil
strict governmental regulations concerning the privacy and security of personal
patient data. Moreover, each research institute and clinic has its own regula-
tions, specific goals, priorities and restrictions to regulate the behaviour of each
of its members. Healthcare systems must therefore often take into account several
regulation environments.
System Evolution. Medical institutions are constantly adapting their sys-
tems to reflect new legislation, software and medical techniques. As these au-
tonomous organizations often operate with a range of aims and priorities, it is
possible that changes may take place without necessarily propagating to all other
parts of the system. In this respect, a change within one sub-system could result
in violations of responsibilities in another sub-system (e.g. by changing data for-
mats). Healthcare systems that consist of multiple organizations must therefore
ensure some formal procedure by which all parties understand and adhere to
their responsibilties. To enable practical deployment, institutions must also be
contractually obliged to adhere to a standard interaction mechanism and data
format, although their internal process or storage technology changes.
3.3 Developing ePCRN-IDEA Recruitment System with ROMAS
In this section, we present the ePCRN-IDEA system design following the RO-
MAS methodology. Figure 2 shows the main structure of ePCRN-IDEA in terms
of the key concepts of organizations, roles, norms and contracts, detailed below.
Organizations and Processes. Several organizations are involved in the
key processes performed in ePCRN-IDEA, as follows. When a research body
wishes to create a new clinical trial, they can inject it through a service called
the Central Control Service (CCS), which is hosted at King’s College London
(KCL). The CCS stores trials within a large database in a pre-defined format
that all researchers must adhere to. Associated with each trial is a list of poten-
tially eligible patients; these lists are generated by the General Practice Research
Database (GPRD), which operates a large data warehouse containing over 12
million up-to-date patient records in the UK. Following this, the trials and their
eligibility lists are distributed to software agents (called LEPIS agents) that oper-
ate on clinicians’ PCs at each participating clinic. LEPIS agents then listen to the
interactions between the practitioner and their local Electronic Health Record
(EHR) database, which is used to store information about patients (e.g. diag-
noses, treatments, demographic data etc.). During consultations, LEPIS agents
compare the patient information against the eligibility lists of all known trials.
If a patient is found to be eligible for a trial, the practitioner is notified, and
if the patient is interested, the system loads a Random Clinical Trial (RCT)
website provided by the research body responsible for the trial, allowing the pa-
tient’s recruitment to be completed. Consequently, the following organizations
are involved: KCL, GPRD, the clinics and the research bodies.
Roles. The system is composed of six different roles presented below.
The GPRD Manager Role is responsible for updating and controlling access
to the GPRD database. It offers a service to pre-compute lists of eligible patients
for individual trials based on complex search criteria (CreateList service). The
role must also offer a service to decide when a GP is authorized to perform re-
cruitment for each trial (AuthorizeGP service). The agent that plays the GPRD
Manager role must also play a role in the governmental body (represented as
the GPRD organization), so it must follow the special governmental legislation
related to the management of this kind of data.
The Researcher Role is responsible for defining the specific features of each
trial under its jurisdiction. Researchers are also responsible for inserting these
trials into the CCS database by means of the service offered by the CCS role
(described below). They are not allowed to directly contact patients unless they
have agreed to participate in a clinical trial under their supervision. For obvious
reasons, each researcher should be part of a specific research institution and
follow its specific normative restrictions.
The CCS Role is a software application responsible for controlling the CCS
database, which stores data about active clinical trials. It offers three services
to the other members of the system: (i) a Register New Trial service that allows
researchers to inject new clinical trials in the database; whenever a Researcher
tries to inject a new trial into the CSS database, the CSS role must verify that
this trial follows the specified standards and regulations; (ii) an Update LEPIS
Database service that allows the clinic’s local database to update its information
about the active clinical trials; and (iii) an Insert/Consult Patients Response
service that allows the response of each patient to be registered (whether they
agree or refuse to participate in a trial). The current implementation of the CCS
role is performed by an agent that is part of the KCL organization. Clearly, this
agent must comply with established norms concerning replication of information,
privacy and programmed machines maintenance.
The CCS Manager Role is responsible for controlling the information in the
CCS (i.e. it has control over the CCS Role). Due to the specific requirements
described by the domain expert, there must be a human responsible for this.
This role must be played by a member of KCL, who must therefore comply with
the restrictions and rules that KCL establishes.
The LEPIS Manager Role is played by a software application that resides
at a clinic and investigates the eligibility of any present patient. There is thus
a LEPIS agent playing this role for each clinic participating in the recruitment
system. LEPIS agents use the CCS service to acquire information about the
clinical trials related to the type of patients that in which its clinic is specialized.
LEPIS agents also provide the GP with a simple interface to notify them of a
patient’s eligibility, as well as the option to launch the RCT website if the patient
is interested.
The GP Role represents a practitioner working in a clinic. If a GP wants
to recruit patients for trials, they must be previously authorized by the GPRD
Manager. This authorization involves the acceptance of some norms related to
privacy, and specific restrictions described for each clinical trial. Clearly, each
GP must also comply with the rules of their own clinic. Finally, patients are con-
sidered external entities for the ePCRN-IDEA system because their interaction
with the system is always executed through their GP.
Norms and Contracts. The Governmental regulations related to the pri-
vacy of patient data and clinical trials are described at a system-wide level; i.e.,
every agent playing a role inside ePCRN-IDEA should comply with them. At
the same time, each institution and clinic defines its own regulations, so the en-
tities of the system should follow the general governmental regulations and the
restrictions established by the institution to which they pertain. For instance,
each LEPIS agent should follow both global and clinic-specific regulations. The
rights and duties that any specific agent implementation must fulfil to play a
role in ePCRN-IDEA are formalized by means of a Social Contract. Even though
contracts are dynamic entities that cannot be completely defined at the design
stage, designers can specify the predefined restrictions that all final contracts of
a specific type should follow. These restrictions are defined in a Contract Tem-
plate, where Hard Clauses indicates mandatory clauses that any contract of this
type must contain and Soft Clauses indicate more flexible recommendations.
Clearly, due to space constraints, a comprehensive set of norms and contracts in
ePCRN-IDEA cannot be listed; thus, we briefly cover a small number of exam-
ples.
Figure 3 describes the LEPIS PlayRole contract template. It specifies that
any agent playing the LEPIS Manager role must detect changes in the EHR
database and after that it must check the suitability of this patient for any trials




NORM ID NORM DESCRIPTION (Deontic,Target,Activation,Expiration,Action,Sanction,Reward) 
O.MatchTrial (OBLIGED, Lepis, Event(changesEHR), - , Match_Trial_Historical,-,-) 
O.UpdateLepis (OBLIGED, Lepis,DAILY, - , Request(UpdateLepis service),-,-) 
P.EHRdb (PERMITTED, Lepis, -,-, Read(EHR database),-,-) 
P.TrialDB (PERMITTED, Lepis, -,-, Read(Lepis trial database),-,-) 
P.ResponsesDB (PERMITTED, Lepis, -,-, Write(Lepis patient responses database),-,-) 
P.consultResponse (PERMITTED, Lepis, -,-, Request(ConsultPatientAnswer service),-,-) 
O.insertResponse (OBLIGED, Lepis, GPInsertResponse, - ,Request(InsertPatientResponse service),-,-) 





























Fig. 3. Phase 2: Lepis PlayRole social contract template
contract includes a norm specifying that the local LEPIS database must be up-
dated with new clinical trials every day (Norm O.UpdateLepis). This clause is
merely a recommendation so that at runtime, LEPIS agents are able to negoti-
ate with the ePCRN-IDEA organization exactly how often they should update
their local database. The remaining clauses relate to the use of the local LEPIS
databases and the service dependencies that LEPIS requires. In this way, each
clinic can implement its own LEPIS agent (if it complies with the required con-
tracts and norms), allowing each clinic to adapt the behaviour of LEPIS in
line with its own priorities. For example, a clinic could decide that its LEPIS
agent should not increase patient queues; e.g. GPs should not be notified during
busy periods. Similarly, each entity that plays any role in ePCRN-IDEA can be
adapted to the different requirements and restrictions of its own institution. Each
institution would thus maintain its own technology, with different implementa-
tions of each role interacting independently of the technological differences.
3.4 Benefits of multi-agent regulation for ePCRN-IDEA
In this section, we revisit the design challenges listed in Section 3.2 to see how
effective ROMAS has been.
Integration of Independent Systems. ROMAS offers an effective design
platform for modelling and integrating the different ePCRN-IDEA systems by
enforcing a high level of abstraction, using many real-world concepts (e.g. orga-
nizations). First, this helps domain experts, who are typically not familiar with
the relevant technology, to gain a better understanding of the system. Beyond
this, it also provides well defined boundaries between different agents and orga-
nizations, allowing individual objectives and regulations to be specified, as well
as maintaining the privacy of each institution’s data and processes. Importantly,
technical and semantic interoperability challenges are also addressed by means
of standardized web service interfaces.
Regulation of Independent Systems. The regulatory needs of ePCRN-
IDEA fit well into the ROMAS principles. Specifically, it allows different nor-
mative environments for each clinic and research institution to be explicitly de-
scribed and combined with global governmental norms. This allows the behaviour
of the different entities to be formally constrained — an extremely important
feature in the medical domain. Furthermore, different vendors and technologies
can be used to implement the agents that play each role. For instance, each
clinic could specify and implement its own LEPIS agents according to its aims,
restrictions and priorities, while maintaining the stability of the system through
global governmental regulations. This is particularly important when potentially
deploying agents across multiple research institutions and clinics from different
countries.
System Evolution. ROMAS offers an effective paradigm for assisting in
system evolution in ePCRN-IDEA. Through norm and contract regulation, each
sub-system can evolve while ensuring that it does not compromise its responsi-
bilities to other parties. Common examples include adaptation to new internal
regulations or to the use of a new software technology. Moreover, global system
evolution can also take place by publishing new contracts and norms, thereby
forcing sub-systems to adapt.
4 Discussion
In the previous sections, we have considered how an existing e-health system
could have been developed using an existing agent methodology, and the benefits
of doing so. We now consider the more general hypothesis presented in Section 1:
that AOSE is highly appropriate for the development of e-health systems.
4.1 Beneficial features of AOSE
AOSE methodologies commonly include analysis and design based on a few key
ideas: agents as autonomous, pro-active, flexible and social entities; interactions
of a flexible and well-defined nature between those agents; and organizations
in which agents operate, modelled either implicitly or explicitly [5, 1, 10]. The
functionality that agents enact in such designs is sometimes modelled as services
[8]. Other features present in some methodologies, including ROMAS, are the
assumptions of openness in the system, and of regulation to be followed by agents
(e.g. norms, responsibilities, rights, contracts, etc. [2, 4, 6, 11, 14]). Through the
lessons learned during the development of ePCRN-IDEA, we now present some
features of AOSE that indicate its suitability for general e-health applications.
Assumption of autonomy. A critical aspect of e-health systems is that
they are comprised of sub-systems that have their own regulations, privacy is-
sues, localised authority, localised flexibility, and so on. For instance, in ePCRN-
IDEA, different policies are applied in different clinics and regions in the UK.
In this context, it is clear that e-health systems must also take into account this
diversity. This stems from factors such as the need to preserve patient confiden-
tiality, the commercial sensitivity of drug development, and from government
involvement and regulation at a local level. The autonomy of agents and organi-
zations assumed at the analysis stages in AOSE means that this is a particularly
well-suited approach.
Allowance for openness. There are millions of independent sites involved
in healthcare in various capacities worldwide (with varying levels of system com-
puterization). A common feature of large-scale e-health systems, such as ePCRN-
IDEA, is the expectation that more sites will join the system as they develop
the technical capability to do so (e.g. new clinics, research institutes etc.). This
means that methodologies with an assumption of an open system are well tai-
lored to e-health. In practice, openness is enabled by a design specifying exactly
how a new party must behave in order to join the system, such as through con-
tracts (as in ROMAS) or roles, as well as lower level concerns such as interfaces
and interaction protocols.
Explicit norms. Due to the confidentiality issues mentioned above, health-
care is highly regulated at all levels, and these regulations must be considered
as a primary influence on any e-health system. Regulations apply both to indi-
vidual clinics and researchers, and across the whole system due to national or
international laws. For instance, in ePCRN-IDEA each clinic and practitioner
must be individually authorised to recruit for each trial. Clearly, e-health also
includes norms of good practice that are not strict regulations but with which it
is preferable to comply. The advantage of a norm-based design approach is that
there is a ready way for developers to specify these regulations explicitly in the
development process, such that they become part of the design. Implementing
the system in a norm-aware platform can ensure their fulfilment, even if the
system has been externally implemented by different providers. For instance,
if the system deals with critical restrictions, a regimented agent platform like
[7] should be used. On the other hand, if the domain of application allows the
violation of norms, an enforcement architecture like [3] should be used.
Domain-like concepts. Agents, norms and organisations directly map to
the important features of the healthcare environment at a high level, for the
reasons described above. That is, healthcare specifically concerns people (pa-
tients and clinicians), the organisations they work for, and the regulations they
must comply with. This aids discussion with domain experts, thereby easing
such things as requirements elicitation and verification (though there are limits,
as discussed below).
4.2 Other development approaches
In theory, an e-health system such as ePCRN-IDEA could be designed by a
single organization in a centralized manner, following one of the many method-
ologies tailored to single, non-distributed systems. However, as described above,
the required data and functionality is distributed among clinics, and their auton-
omy makes this unrealistic. Also, for most applications, the number of patients,
clinics, trials etc. could produce a scalability problem.
Turning to more comparable development views, a service-oriented approach
to development is clearly appropriate in some respects. It assumes some auton-
omy, in that services can be separately hosted and maintained, and allows for
some openness, as existing published interfaces may be implemented by new ser-
vices. However, a service-oriented application is generally controlled ultimately
by a single client, the interfaces only partially specify how a service should be-
have, and there are no explicit norms (though service-level agreements can act
as contracts for low-level quality of service demands).
Methodologies based on concepts of objects or components, regardless of the
particularities of the methods themselves, also suffer from having less domain-
like concepts than AOSE. This point is not healthcare-specific, but significant
in any domain in which the requirements relate to user interaction rather than
merely system component interaction. Objects and components will normally
have parallels in the domain, but these will be of less direct concern than the
people, organisations and regulations.
The comparison above is not to say that services or objects are irrelevant to
developing e-health systems, but are inadequate in themselves compared to an
AOSE approach. Many AOSE methodologies, including ROMAS, utilise service-
oriented and object-oriented specifications of the functionality performed by
agents.
4.3 AOSE weaknesses
There are two weaknesses of the current approach in applying ROMAS to
ePCRN-IDEA. Although they are weaknesses of ROMAS, we believe them to
apply to current AOSE methodologies more generally.
First, while conceptualizing the system in terms of agents, organizations and
norms was found to be intuitive by domain experts, the language itself was
not. There are terms in different areas of healthcare that are commonly used,
and it would help the requirements and analysis process if software engineering
principles could adopt these rather than agent abstractions. For example, when
‘patient’ is so critical a concept to the healthcare domain, modelling them as
abstract ‘agents’ only obfuscates the intention. Similarly, the context in which
the clinical researcher operates may be an organization, but for medics, such
organizations are quite distinct from the ‘sites’, such as clinics or hospitals, from
which patients are recruited.
Second, while there are explicit regulations in the domain, there are also
many implicit good practices for medicine and healthcare. Capturing these as
part of the engineering process is possible but prone to accidental exclusion.
It is unclear why these need to be captured every time, and could instead be
an embedded part of the methodology. In consequence, in our ongoing work,
we are investigating how to address both weaknesses, and provide an AOSE
methodology tailored more specifically to e-health.
5 Conclusions and future work
This paper explores the suitability of AOSE techniques for the development of
complex systems in the healthcare domain. To investigate this domain, we have
designed a real-time system for the identification of eligible patients for clinical
trials based on an AOSE methodology. The results obtained show that the use of
high level AOSE concepts, such as organizations, roles, norms and contracts, is
beneficial to analyze and design health systems. Furthermore, it has been shown
that the use AOSE techniques will produce flexible systems that can deal with
the dynamics of the normative and technological environment.
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